Search

Your search keyword '"Kwiecinski, H."' showing total 157 results

Search Constraints

Start Over You searched for: Author "Kwiecinski, H." Remove constraint Author: "Kwiecinski, H."
157 results on '"Kwiecinski, H."'

Search Results

1. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia

8. Identification of symbol digit modality test score extremes in Huntington's disease

9. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

16. Suicidal ideation in a European Huntington's disease population

17. Randomized Trial of Thymectomy in Myasthenia Gravis

18. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

19. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study

20. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

21. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

22. NMDA receptor gene variations as modifiers in Huntington disease: a replication study

23. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

24. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

25. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

26. Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

27. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease

28. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

30. NMDA receptor gene variations as modifiers in Huntington disease

31. Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

32. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

33. Electrophysiologic correlations with clinical outcomes in CIDP

34. Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy

35. Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

36. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

37. 250 mu g or 500 mu g interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

38. ELECTROPHYSIOLOGY IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY WITH IGIV

39. Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study

40. Weight loss in Huntington disease increases with higher CAG repeat number

41. Health-related quality of life in multiple sclerosis: Effects of natalizumab

42. Acute Stroke

43. Neurology training around the world

46. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia.

47. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia

48. Mutations and polymorphisms of the CLCN2 gene in idiopathic epilepsy.

49. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway.

50. Correlating phenotype and genotype in the periodic paralyses

Catalog

Books, media, physical & digital resources